Please login to the form below
Article 50
This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.
UK businesses leaning towards second Brexit vote
May is resisting any moves to extend the Article 50 process under which the UK is due to leave the EU, and the Confederation of British Industry (CBI) has indicated that ... CBI director general Josh Hardie said: “If there were to be an extension [of
Latest news
-
Industry pleads for compromise after Brexit defeat
and that means suspending Article 50, which may be problematic. ... Financial Times writer Jim Pickard tweeted yesterday evening that Chancellor Philip Hammond has told business leaders that the EU won’t consider an extension to Article 50 until the UK
-
Crunch time as Brexit deal faces ‘meaningful vote’
of legislative affairs Nikki da Costa told the BBC’s Today programme this morning she expected it to be within the 50 to 80 range. ... At the same time, a group of Remain politicians has published proposed legislation that would implement a
-
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
As mentioned above, draft Article 50 in particular confirms that all existing registered EU IPRs will be duplicated as comparable UK national rights at the end of the transition period. ... For example:. Geographical indications:Draft Article 50(2)
-
UK pharma welcomes Brexit breakthrough
the Article 50 negotiations.
-
EU and UK pharma leaders appeal directly to Brexit negotiators
to collaborate with the EU" on the regulation of medicines after 30 March 2019 - the date when the UK officially leaves the EU under the two-year Article 50 process.
More from news
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest Intelligence
-
Leave or remain? Winning the employee referendum
killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but
-
The Patient Safety Challenge
The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
-
Macron, Merkel and May: implications of the 2017 elections for the life science industry
50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period
-
Brexit: the facts (and the alternative facts)
How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
-
Brexit: Implications for the pharma industry
Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Random42 Named in Alantra’s Pharma Fast 50.
The London based scientific communication studio have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry. ... For more on the Pharma Fast 50 read the full article: .
-
Brexit and Pharma: A match made in hell.
Countless other challenges remain, but we need to move forward, especially now that we have witnessed the triggering of article 50.
-
Research Partnership has been ranked in the Pharma Times Pharma Fast 50
Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research Partnership
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Manager / Account Director
-
Competative
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Novartis forges AI alliance with Oxford University
- J&J earnings top expectations, but feels the squeeze in US
- Researchers reverse Alzheimer’s memory loss in mice
- Editas CEO exits the CRISPR firm ahead of first clinical trial
- A dynamic and challenging environment – what it’s like starting a career in MedComms
- UniQure cleared to start Huntington gene therapy trial
- HSJ Partnership Awards 2019 shortlist announced
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
